In people with obesity, fat tissue that makes more estrogen seems to be linked to having more total body fat.
Scientific Claim
In obese adults, higher levels of aromatase mRNA in subcutaneous adipose tissue are associated with greater overall body fat mass (BMI), suggesting local estrogen production may relate to generalized obesity.
Original Statement
“Generalized obesity (BMI) was associated with increased aromatase mRNA (r = 0·35, P < 0·05).”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is cross-sectional and observational; it shows correlation, not causation. The abstract implies predictive or causal roles, but only association is supported. Verb strength must be conservative.
More Accurate Statement
“In obese adults, higher levels of aromatase mRNA in subcutaneous adipose tissue are associated with greater overall body fat mass (BMI), though causation cannot be determined from this observational data.”
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether the association between adipose aromatase mRNA and BMI is consistent across diverse populations and adjusted for confounders like age, sex, and insulin resistance.
Whether the association between adipose aromatase mRNA and BMI is consistent across diverse populations and adjusted for confounders like age, sex, and insulin resistance.
What This Would Prove
Whether the association between adipose aromatase mRNA and BMI is consistent across diverse populations and adjusted for confounders like age, sex, and insulin resistance.
Ideal Study Design
A meta-analysis of 15+ high-quality cross-sectional or longitudinal studies in adults aged 25–65 with BMI 21–40 kg/m², measuring subcutaneous adipose aromatase mRNA via qPCR and BMI, with adjustment for sex, age, insulin sensitivity, and physical activity, using standardized methods.
Limitation: Cannot establish whether changes in aromatase cause BMI changes or are a consequence of obesity.
Randomized Controlled TrialLevel 1bWhether pharmacologically increasing or inhibiting aromatase activity in adipose tissue directly alters body fat mass over time.
Whether pharmacologically increasing or inhibiting aromatase activity in adipose tissue directly alters body fat mass over time.
What This Would Prove
Whether pharmacologically increasing or inhibiting aromatase activity in adipose tissue directly alters body fat mass over time.
Ideal Study Design
A double-blind RCT of 100 obese adults (BMI 30–35) randomized to 12 weeks of a selective aromatase inhibitor (e.g., anastrozole 1mg/day) vs. placebo, with primary outcome of change in total body fat mass via DXA scan, controlling for diet and activity.
Limitation: Cannot determine if effects are due to systemic vs. local adipose aromatase inhibition.
Prospective Cohort StudyLevel 2bWhether baseline aromatase mRNA levels predict future weight gain or fat distribution over 5+ years.
Whether baseline aromatase mRNA levels predict future weight gain or fat distribution over 5+ years.
What This Would Prove
Whether baseline aromatase mRNA levels predict future weight gain or fat distribution over 5+ years.
Ideal Study Design
A 5-year prospective cohort of 500 healthy adults aged 30–50 with baseline subcutaneous fat biopsies measuring aromatase mRNA and serial BMI and fat distribution measurements via DXA and waist-hip ratio.
Limitation: Still observational; residual confounding (e.g., diet, hormones) may influence results.
Evidence from Studies
Supporting (1)
Intra‐adipose sex steroid metabolism and body fat distribution in idiopathic human obesity
The study found that people with more body fat had higher levels of a specific enzyme (aromatase) in their fat tissue, which makes estrogen — and this matches the claim that more fat means more of this enzyme, possibly helping explain why fat builds up.